XGENOMES CORP. — National Aeronautics and Space Administration STTR Phase I: GRAVITY-INDEPENDENT SINGLE-MOLECULE MULTI-OMIC SEQUENCING
XGENOMES CORP. — STTR Phase I award from National Aeronautics and Space Administration.
Phase I STTR feasibility signal
- Phase I awards fund proof-of-concept work. For capture teams, they mark early interest from National Aeronautics and Space Administration in a technical approach.
- Watch for Phase II follow-ons from the same firm/topic family — that conversion path is where budgets and transition pressure rise.
- Obligated amount $224,923. Cross-check similar awards in the same agency and technology tags for going-rate context.
- Tagged technology areas: Space & Satellite, Human Performance & Medical. Follow those hubs for open topics and peer winners in the same cluster.
Summary
XGENOMES CORP. was awarded about $225,000 by NASA for a Phase I STTR project to develop a single-molecule multi-omic sequencing system that functions without gravity. This technology aims to enable biological analysis of samples in space environments.
- Amount
- $224,923
- Agency
- National Aeronautics and Space Administration · National Aeronautics and Space Administration
- Program / Phase
- STTR · Phase I
- NAICS
- 541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
- Place of performance
- MA
- Period
- 2026-09-30 → 2027-10-29
Technology domains
Description
STTR PHASE I GRAVITY-INDEPENDENT SINGLE-MOLECULE MULTI-OMIC SEQUENCING